People

The Center faculty come from all four UCSF schools and conduct research and teaching in every aspect of tobacco control, from efforts by the tobacco industry to manipulate international politics to the molecular biology of nicotine addiction.

 

Suzaynn Schick, PhD

Associate Professor
Medicine

I study the health effects of air pollution in human subjects. I focus on the chemistry and toxicity of smoke and on how smoking and using electronic cigarettes can cause heart and lung disease. My analysis of tobacco industry research showed that sidestream cigarette smoke (the primary constituent of secondhand cigarette smoke) is more toxic than the smoke that smokers inhale and that secondhand smoke becomes more toxic as it ages.

Laura Schmidt, PhD, MPH

Professor in Residence
Institute for Health Policy Studies

Laura A. Schmidt, PhD, is a Professor of Health Policy in the School of Medicine at the University of California at San Francisco. She holds a joint appointment in the Philip R. Lee Institute for Health Policy Studies and the Department of Anthropology, History and Social Medicine. Dr. Schmidt is also Co-Director of the Community Engagement and Health Policy Program for UCSF’s Clinical and Translational Sciences Institute.

Steve Schroeder, MD

Professor
Medicine

Dr. Schroeder is Distinguished Professor of Health and Health Care, Division of General Internal Medicine, Department of Medicine, UCSF, where he also heads the Smoking Cessation Leadership Center. The Center, funded by the Robert Wood Johnson Foundation and the Truth Initiative, works with leaders of more than 80 American health professional organizations and health care institutions to increase the cessation rate for smokers.

Mark Schumacher, MD, PhD

PROF-HCOMP
Anesthesia

Dr. Schumacher is Professor and Chief of the Division of Pain Medicine in the Department of Anesthesia and Perioperative Care, University of California, San Francisco. He has a clinical, research and educational focus on pain medicine with an emphasis on the development of evidence – based pain care into general clinical practice that utilize non-addictive modalities to improve both the quality and safety of analgesic care. Dr.

Joel Simon, MD, MPH

Professor Emeritus
Medicine

Research has centered on hospital-based and out-patient clinical trials of smoking cessation. Completed studies include: Transdermal Nicotine Therapy for Hospitalized Smokers and Bupropion for Hospital-Based Smoking Cessation.    Dr.

Neiloy Sircar, JD, LLM

Postdoctoral Scholar
Cardiovascular Research Inst

Neil Sircar, JD, LLM is a human rights lawyer specializing in global and public health, global governance, and health in humanitarian crises. He recently concluded a Fogarty Global Health Fellowship with the National Institutes for Health through the Northern Pacific Global Health Consortium at the University of Washington. He is principal investigator on a study for assessing the implementation of human rights-based approaches to HIV testing and notification in Kenya with the prominent Kenyan non-governmental organization Kenya Legal and Ethical Issues Network.

Elizabeth Smith, PhD

Professor
Social Behavioral Sciences

Dr. Smith's work focuses on tobacco control policy, particularly approaches to the tobacco endgame. Past projects include work on the tobacco industry's influence on and relationships with the lesbian, gay, bisexual and transgender communities, tobacco industry interest in diet and obesity issues, tobacco product waste and pollution, and tobacco control policy issues in the U.S. military.

Joanne Spetz, PhD

Professor
Institute for Health Policy Studies

Joanne Spetz, Ph.D., is the Director of the Philip R. Lee Institute for Health Policy Studies and Brenda and Jeffrey L. Kang Presidential Chair in Healthcare Finance. She also is Associate Director for Research at Healthforce Center at UCSF. She holds faculty appointments in the Department of Family and Community Medicine and in the School of Nursing. Her fields of specialty are economics of the health care workforce, organization and quality of health care services, and policies that affect use of and treatment for illicit drugs.

Matthew Springer, PhD

Professor
Medicine

RESEARCH INTERESTS:

Dr. Matthew L. Springer received his BA from the University of California, Berkeley in 1985 and his PhD from Stanford University in 1992. He did postdoctoral research at Stanford and continued his research there as a senior scientist until joining the UCSF faculty in 2003, where he is currently one of two non-clinicians on the faculty of the Division of Cardiology. The close juxtaposition of his basic research background with the clinical cardiologists in the Division has resulted in an active translational research program.

Gideon St Helen, PhD

Assistant Professor
Medicine

The focus of my research program in the Division of Clinical Pharmacology, as shown in the image below, is the utility and evaluation of biological markers (biomarkers) of tobacco use and exposure for epidemiology, risk assessment, product regulation, and identification of susceptibility factors.

Research Themes Visual- information below

Hugh Sturrock, PhD

Assistant Professor
M_Epidemiology & Biostatistics

Hai-Yen Sung, PhD

Professor
Institute for Health & Aging

Dr. Sung is Professor of Health Economics at the Institute for Health & Aging at UCSF. Her tobacco-related research areas focus on 1) estimating the healthcare costs of cigarette smoking, other tobacco use, and secondhand smoke exposure; 2) economic evaluation of tobacco taxation, other tobacco control policies, and smoking cessation intervention programs; 3) economic impact of smoking on vulnerable populations such as African Americans, Hispanics, low-income people, and persons with mental illness; and 4) global health economics of tobacco use. Dr.

Pages